For the fast diagnosis of acute myocardial infarction. Troponin is the preferred biomarker in defining AMI according to the European Society of Cardiology (ESC) guidelines.5 In addition, it is the gold standard to distinguish between AMI and non-AMI patients. Roche Troponin T-high sensitive (TnT-hs) can reduce the time needed to rule-in or rule-out NSTEMI to as little as just 1 hour.
Reliable, high-volume testing for the detection of novel coronavirus (SARS-CoV-2)
Reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2
The cobas c 501 module is a mid volume analyzer comprised of a photometric unit for a broad range of clinical chemistry assays and an ISE unit for ion-selective electrode determinations of sodium, potassium, and chloride in serum, plasma, or urine. This module is also capable of measuring HbA1c levels in whole blood, making it a truly flexible and versatile analyzer.
The cobas c 311 analyzer is an automated analyzer including software, intended for running qualitative, semi- quantitative and quantitative clinical chemistry assays as well as ion-selective measurements.
Cedex Sample Cups are designed for use with automated Cedex HiRes Analyzer. The material properties, size, and volume are optimally adapted for cell culture sample preparation and measurement. Cedex Sample Cups are designed for single use only.
The NimbleGen MS 200 Microarray Scanner is the first scanner optimized to unleash the full potential and capture the complete picture from NimbleGen DNA microarrays. The MS 200 offers 2 micron resolution and heightened sensitivity to achieve high data quality and confident results from high-density NimbleGen microarrays of today and tomorrow. Critical to the the workflow, NimbleScan and SignalMap software are included to ana…
Stand alone analyser for clinical chemistry. Flexible system for consolidating routine and special chemistry workloads. On-board capacity of 45 tests and throughput of up to 480 tests per hour. For analysis of serum, plasma, urine, cerebrospinal fluid (CSF), hemolysate and whole blood. Benefits: Comprehensive workload consolidation - cobas c 311, with up to 45 tests on board, offers consolidated testing from a menu of mor…
The DISCOVERY ULTRA research instrument for IHC/ISH promises the highest level of protocol flexibility for the most challenging assays and for rapid assay development. The thirty independent slide drawers allow for titration capability for each individual slide. This instrument offers enhanced multiplexing and immunofluorescence capabilities. It also saves valuable development time with continuous access to bulks, waste and re…
Accu-Chek Active test strips are designed for easy handling and allow for dosing outside of the meter
An immunoassay for the quantitative determination of HE4 in human serum and plasma, this test is used as an aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 values should be used in conjunction with other clinical findings used for monitoring ovarian cancer. This assay is intended for use on the cobas e 411, cobas e 601, cobas e 602, Elecsys 2010…
The Multiplate® analyzer is an easy-to use instrument to determine platelet function in small quantities of whole blood in a highly standardized manner. The 5 channel analyzer with a broad menu of CE marked tests has been featured by over 200 Medline-listed articles and has been reported by several groups to be useful in tailoring anti-platelet therapy as well as improving the management of bleeding complications in surgical p…
The VENTANA MMR RxDx Panel is the first and only immunohistochemistry-based assay approved to identify endometrial carcinoma patients eligible for treatment with JEMPERLI (dostarlimab).
Remain at the forefront of companion diagnostics and personalized medicines. The BenchMark ULTRA PLUS system uses an unprecedented, fully-automated workflow for immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining to improve turnaround time and decrease touchpoints.
